NCT00069719CompletedPhase 2
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Alcon Research
- Locations
- 1
Study Overview
Brief Summary
To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension;
- •logMAR visual acuity not worse than 0.6.
Exclusion Criteria
- •Clinically relevant ophthalmic or systemic conditions may be excluded.
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension PatientsOcular HypertensionOpen-angle GlaucomaNCT00069706Alcon Research118
Completed
Phase 3
Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension PatientsOcular HypertensionOpen-angle GlaucomaNCT00288951Alcon Research690
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT00333125Alcon Research319
Completed
Phase 2
RMP-A03 Ocular Suspension in Patients With PterygiumPterygiumNCT05794204Suzhou Raymon Pharmaceuticals Company, Ltd.77
Completed
Phase 4
Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStentsSubjects With Primary Open-angle Glaucoma (POAG)NCT01252888Glaukos Corporation39